# Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics

> **NCT04870411** · — · TERMINATED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 78 (actual)

## Conditions studied

- Autoimmune Diseases
- Inflammatory Disorder

## Interventions

- **BIOLOGICAL:** Blood sample

## Key facts

- **NCT ID:** NCT04870411
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2021-05-12
- **Primary completion:** 2021-08-31
- **Final completion:** 2022-03-13
- **Target enrollment:** 78 (ACTUAL)
- **Why stopped:** Most of the patients were already vaccinated
- **Last updated:** 2025-09-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04870411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04870411, "Immunological Response to COVID-19 Vaccine in Patients With Autoimmune and Inflammatory Diseases Treated With Immunosuppressants and/or Biologics". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04870411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*